Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Logothetis

Showing results (181-190 of 430) with videos related to

Pageof 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancerC J Logothetis, K K Wu, L D Finn, et al.
Cancer Informatics|May 22, 2009
Merging microarray data, robust feature selection, and predicting prognosis in prostate cancerJing Wang, Kim Anh Do, Sijin Wen, et al.
Cancer Gene Therapy|July 27, 1999
Tumor-suppressive activity of CD66a in prostate cancerW Luo, M Tapolsky, K Earley, et al.
Annals of Clinical and Laboratory Science|November 1, 1996
Serum calcitonin in small cell carcinoma of the prostateS J Sim, A B Glassman, J Y Ro, et al.
Urologic Oncology|January 13, 2011
Evidence for the existence of an organ specific, androgen-independent pathway of progression in patients with metastatic prostate cancerJ T Hsieh, H C Wu, Y Wang, et al.
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
The Journal of Urology|January 1, 1989
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experienceC J Logothetis, F H Dexeus, C Chong, et al.
Urology|July 1, 1991
Serum biomarkers in metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
Urology|February 1, 1989
Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndromeB Têtu, J Y Ro, A G Ayala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinomaLance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Pageof 43

Showing results (181-190 of 430) with videos related to

Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancerC J Logothetis, K K Wu, L D Finn, et al.
Cancer Informatics|May 22, 2009
Merging microarray data, robust feature selection, and predicting prognosis in prostate cancerJing Wang, Kim Anh Do, Sijin Wen, et al.
Cancer Gene Therapy|July 27, 1999
Tumor-suppressive activity of CD66a in prostate cancerW Luo, M Tapolsky, K Earley, et al.
Annals of Clinical and Laboratory Science|November 1, 1996
Serum calcitonin in small cell carcinoma of the prostateS J Sim, A B Glassman, J Y Ro, et al.
Urologic Oncology|January 13, 2011
Evidence for the existence of an organ specific, androgen-independent pathway of progression in patients with metastatic prostate cancerJ T Hsieh, H C Wu, Y Wang, et al.
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
The Journal of Urology|January 1, 1989
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experienceC J Logothetis, F H Dexeus, C Chong, et al.
Urology|July 1, 1991
Serum biomarkers in metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
Urology|February 1, 1989
Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndromeB Têtu, J Y Ro, A G Ayala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinomaLance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Pageof 43